Tarbox Family Office’s BioTelemetry, Inc. BEAT Stock Holding History

Tarbox Family Office’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-41	Closed	-$3K	–	1187
2020 Q4	$3K	Hold	41	–	–	﹤0.01%	767
2020 Q3	$2K	Buy	41 +3	+8%	+$125	﹤0.01%	893
2020 Q2	$2K	Buy	38 +13	+52%	+$582	﹤0.01%	885
2020 Q1	$1K	Sell	25 -71	-74%	-$3.27K	﹤0.01%	1092
2019 Q4	$4K	Buy	+96	New	+$4.16K	﹤0.01%	619

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Tarbox Family Office's BEAT Position: Q1 2021 in Review

Tarbox Family Office sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 41 shares — an estimated $3K sold.

Tarbox Family Office first reported a position in BEAT in Q4 2019 and held it in 5 quarters. The position peaked at $4K in Q4 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Tarbox Family Office reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Tarbox Family Office sold 41 BioTelemetry, Inc. shares in Q1 2021, an estimated $3K.
Tarbox Family Office first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 5 quarters.
Tarbox Family Office's BioTelemetry, Inc. position peaked at $4K in Q4 2019.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Tarbox Family Office's 13F filing for Q1 2021, filed 27 Apr 2021.